...
首页> 外文期刊>Sao Paulo Medical Journal >Ultrasound-guided adductor canal block using levobupivacaine versus periarticular levobupivacaine infiltration after totalknee arthroplasty: a randomized clinical trial
【24h】

Ultrasound-guided adductor canal block using levobupivacaine versus periarticular levobupivacaine infiltration after totalknee arthroplasty: a randomized clinical trial

机译:超声引导下的左旋布比卡因与左旋布比卡因关节穿刺术后左环布比卡因的浸润的内收管阻滞:一项随机临床试验

获取原文
           

摘要

BACKGROUND: Both postoperative pain control and range of motion are important in total knee arthroplasty (TKA). However, in the literature, there is little comparison of peripheral nerve blocks and periarticular infiltration techniques using levobupivacaine. The aim of our study was to measure pain with visual analogue scale (VAS) and knee range of motion (ROM) between in patients undergoing adductor canal block (ACB) for TKA using levobupivacaine compared to periarticular levobupivacaine infiltration (PAI-L). DESIGN AND SETTING: Prospective randomized clinical trial in a university hospital. METHODS: Patients aged 40-85 years who underwent unilateral TKA were included; 39 were treated withperiarticular infiltration using 40 ml (0.125 mg) of levobupivacaine (PAI-L group); and 40 were treated with ACB using 20 ml of 0.25% levobupivacaine (ACB-L group). Postoperative pain scores at rest and during active physical therapy were assessed using a VAS, along with knee ROM in flexion and extension. In addition, 100-foot walking time results, total morphine consumption and time of first analgesia requirement were recorded postoperatively. RESULTS: VAS scores at rest and during active physical therapy and the total amount of morphine consumed were lower in the ACB-L group than in the PAI-L group (P 0.05). In contrast, knee ROM in flexion and extension and 100-foot walking times were greater in the PAI-L group than in the ACB-L group (P 0.05). CONCLUSION: ACB-L was superior to PAI-L regarding pain treatment after TKA; however, PAI-L was superior to ACB-L regarding postoperative ROM and walking ability. CLINICAL TRIAL REGISTRY: ACTRN-12618000438257.
机译:背景:术后疼痛控制和运动范围在全膝关节置换术(TKA)中均很重要。然而,在文献中,使用左旋布比卡因的周围神经阻滞和关节周围浸润技术几乎没有比较。我们研究的目的是通过左旋布比卡因与关节周围左旋布比卡因浸润(PAI-L)相比,对接受左旋布比卡因的内收管阻滞(ACB)进行TKA的患者进行视觉模拟量表(VAS)和膝关节活动度(ROM)测量。设计与地点:某大学医院的前瞻性随机临床试验。方法:纳入年龄为40-85岁的单侧TKA患者。 39例患者接受了40 ml(0.125 mg)左旋布比卡因的关节腔浸润治疗(PAI-L组);使用40 ml 0.25%左旋布比卡因的ACB治疗40例(ACB-L组)。使用VAS评估膝关节ROM屈伸时的静止和积极物理治疗期间的术后疼痛评分。此外,术后记录100英尺的步行时间结果,总吗啡消耗量和首次镇痛时间。结果:ACB-L组在静息状态和积极物理治疗期间的VAS评分以及所消耗的吗啡总量均低于PAI-L组(P <0.05)。相比之下,PAI-L组的膝关节ROM屈伸,100英尺步行时间要比ACB-L组大(P <0.05)。结论:在TKA后的疼痛治疗方面,ACB-L优于PAI-L。然而,PAI-L在术后ROM和行走能力方面优于ACB-L。临床试验注册号:ACTRN-12618000438257。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号